Today’s episode is all about AML (acute myeloid leukemia), including the usual presentation, diagnostic work-up, risk stratification (and tricks to remember these), molecular testing, and treatment options for first-line, as well as relapsed/refractory disease.
Sep 28
ctDNA & MRD: Current Applications, Limitations & What’s Next
This week’s episode we are very excited to welcome back our special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We further cover ... Show More
19m 12s
Sep 21
ctDNA, Liquid Biopsies, Methylation, NGS: What Does It All Mean?
This week’s episode we are very excited to welcome a special guest Dr. Hatim Husain, MD, a medical oncologist and physician-scientist at UC San Diego Moores Cancer Center, whose clinical and research expertise focuses on lung cancer and precision oncology. We cover the topic of l ... Show More
27 m
Sep 2024
Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
<p>In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ... Show More
31m 56s
Nov 2024
Episode 122: AML Series, Pt 8 - AML Maintenance Therapies
<p>This week, we continue our series focusing on acute myeloid leukemia. In this episode, we talk about maintenance therapies in AML.</p><p>Episode contents: </p><p>- A recap of cytarabine consolidation </p><p>- Why do we do maintenance therapy?</p><p>- What are hypomethylating a ... Show More
33m 15s
Sep 2024
Episode 115: AML Series, Pt. 1 - CHIP, CCUS, ICUS, oh my!
<p>This week, we kick off a new series focusing on myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). In this first episode, we discuss the alphabet soup of premalignant hematologic conditions including CHIP, CCUS, and ICUS, before moving onto MDS and AML in future ... Show More
35m 14s
Oct 2024
Episode 117: AML Series, Pt. 3 - AML Induction: Definitions and Overview
<p>In this week’s episode, we start our three-part discussion on AML induction, this week focusing on key definitions and an overview of treatment. Also, if you have not done so, please do check out our hemepath series to ensure you can more easily follow along with this conversa ... Show More
27m 22s
<p>In this episode, we review the high-yield topic of <a href="https://step2.medbullets.com/oncology/120467/acute-lymphoblastic-leukemia-all">Acute Lymphoblastic Leukemia (ALL)</a> from the Oncology section.</p>
<p>Follow <a href="https://step1.medbullets.com/">Medbullets</a> on ... Show More
<p class="" style="white-space:pre-wrap;">Emergencies happen in hematology and oncology. This is a fact. But how do we manage these emergencies? Look no further. </p><p class="" style="white-space:pre-wrap;">In this episode, we’ll talk about one of the key hematologic malignancie ... Show More
